2 results
Approved WMOCompleted
Part 1: To assess the safety and effectiveness of subcutaneous golimumab 50 mg (SC-GLM50), administered by autoinjection once monthly during 6 months, when combined with different DMARD regimens used in daily rheumatology. Part 2: In subjects who…
Approved WMOPending
To evaluate the performance of patients with dental implants that have been restored with CAD CAM 3D printed resin/polymer screw retained crowns on Straumann dental implants. As no clinical study has been carried out on these materials up till now…